BRIEF published on 04/28/2026 at 22:05, 12 days 13 hours ago FORVIA lance un programme de rachat d'actions Rachat D'actions Technologie Automobile Confiance Du Marché Forvia Primes De Performance
BRIEF published on 04/28/2026 at 22:00, 12 days 13 hours ago Piramal Pharma Limited Reports FY26 Financial Results Strategic Investment Revenue Decline Segment Growth Piramal Pharma Limited Financial Results 2026
BRIEF published on 04/28/2026 at 22:00, 12 days 13 hours ago Piramal Pharma Limited publie ses résultats financiers pour l'exercice 2026 Investissement Stratégique Baisse Des Revenus Croissance Du Segment Piramal Pharma Limited Résultats Financiers 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 14 hours ago VAT Group AG Shareholders Approve Board Proposals and 12% Dividend Increase Dividend Increase VAT Group AG Shareholder Resolutions Board Re-elections AGM 2026
BRIEF published on 04/28/2026 at 21:05, 12 days 14 hours ago Les actionnaires de VAT Group AG approuvent les propositions du conseil d'administration et une augmentation de 12 % du dividende. Réélections Du Conseil D'administration Résolutions Des Actionnaires Augmentation Des Dividendes Groupe TVA AG Assemblée Générale Annuelle 2026
BRIEF published on 04/28/2026 at 20:40, 12 days 15 hours ago GenSight Biologics annonce son Assemblée Générale Mixte de 2026 Actionnaires Assemblée Générale Documents Préparatoires Thérapie Génique GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 12 days 15 hours ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 12 days 15 hours ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 12 days 15 hours ago GenSight Biologics programme son assemblée générale annuelle pour mai 2026 Conformité Réglementaire Assemblée Générale Annuelle Thérapie Génique Relations Avec Les Investisseurs Informations Destinées Aux Actionnaires
BRIEF published on 04/28/2026 at 20:05, 12 days 15 hours ago Mise à disposition du rapport financier annuel 2025 de Bogart AMF Rapport Financier Commissaires Aux Comptes Jacques Bogart Exercice 2025
Published on 05/11/2026 at 09:05, 2 hours 42 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 3 hours 42 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/09/2026 at 01:30, 2 days 10 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/11/2026 at 11:36, 11 minutes ago LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 30 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:10, 37 minutes ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 11:09, 38 minutes ago Marinomed Biotech AG announces progress with Tacrolimus Eyedrops for Entry into the Compounding Market
Published on 05/11/2026 at 10:48, 59 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 59 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 2 hours 31 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 16 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
